Clinuvel Pharmaceuticals Limited
CLVLY · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | $0 | $30,605 | $20,878 |
| Dep. & Amort. | $0 | $0 | $789 | $758 |
| Deferred Tax | $0 | $0 | -$19,754 | $6,065 |
| Stock-Based Comp. | $0 | $0 | $8,990 | $6,121 |
| Change in WC | $0 | -$5,061 | -$3,217 | $5,891 |
| Other Non-Cash | $41,095 | $42,115 | $19,500 | $159 |
| Operating Cash Flow | $41,095 | $37,054 | $36,912 | $39,872 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$299 | -$5,576 | -$1,028 | -$434 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$47,418 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$23,458 | $0 | $0 |
| Investing Cash Flow | -$47,716 | -$29,034 | -$1,028 | -$434 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $189 | $4,155 | $0 | $0 |
| Stock Repurch. | -$441 | -$4,909 | $0 | $0 |
| Dividends Paid | -$2,504 | -$2,470 | -$1,976 | -$1,235 |
| Other Fin. Act. | -$183 | -$347 | -$264 | -$268 |
| Financing Cash Flow | -$2,939 | -$3,572 | -$2,240 | -$1,504 |
| Forex Effect | $2,379 | -$1,140 | $1,660 | $884 |
| Net Chg. in Cash | -$7,180 | $3,308 | -$3,542 | -$9,732 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,201 | $31,893 | $27,409 | $37,141 |
| End Cash | $28,021 | $35,201 | $23,867 | $27,409 |
| Free Cash Flow | $40,797 | $31,478 | $35,885 | $39,438 |